Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Exercise/Conversion of 12,282 REGN shares, $4.69M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 12,282 | $4.69M |
| Dec 9, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,476 | n/a |
| Nov 24, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 14,450 | $8.03M |
| Dec 18, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 702 | $513.0K |
| Dec 10, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,332 | n/a |
| Jul 12, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1,866 | $2.03M |
| Jun 25, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 14,450 | $8.03M |
| Jun 12, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift | 1,608 | n/a |
| May 22, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1,865 | $1.86M |
| Feb 28, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1,000 | $990.0K |